ENLV Enlivex Therapeutics Ltd.

Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

$12.98
As of 03/08/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
Israel

11/02/2017
15,759,878
1,006,938
$204,720,815
0.00%
SEC Edgar Online
20-F



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
7.18
0.00
-30.97%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy